论文部分内容阅读
目的探讨思密达灌肠治疗慢性非特异性结肠炎的临床效果。方法将我院收治的60例慢性非特异性结肠炎患者,随机分为对照组和观察组,每组各30例,两组在常规治疗的基础上,对照组给予黄连素灌肠治疗,观察组给予思密达灌肠治疗,比较两组治疗效果及不良反应发生情况。结果对照组总有效率73.3%,观察组总有效率93.3%,两组总有效率经统计学分析,差异有统计学意义(P<0.05)。两组治疗过程中均未见明显不良反应发生。结论思密达灌肠治疗慢性非特异性溃疡性结肠炎效果优于黄连素灌肠治疗,且不良反应少,使用方便,值得临床推广应用。
Objective To investigate the clinical effect of Smecta enema on chronic nonspecific colitis. Methods Sixty patients with chronic nonspecific colitis treated in our hospital were randomly divided into control group and observation group, with 30 cases in each group. On the basis of routine treatment, the two groups were given berberine enema treatment and the observation group was given Smecta enema treatment, the treatment effect and adverse reactions were compared between the two groups. Results The total effective rate of the control group was 73.3%, the total effective rate of the observation group was 93.3%. The total effective rate of the two groups was statistically analyzed (P <0.05). No significant adverse reactions occurred in both groups during the course of treatment. Conclusion Smecta enema treatment of chronic non-specific ulcerative colitis is better than berberine enema treatment, and less adverse reactions, easy to use, it is worthy of clinical application.